- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06609239
중등도 천식 성인 참가자를 대상으로 한 Lunsekimig(SAR443765)의 장기 안전성 및 유효성 평가. (AIRPHRODITE)
연구 DRI16762에 참여한 중등도~중증 천식 성인 참가자를 대상으로 피하 Lunsekimig의 장기적인 안전성과 유효성을 평가하기 위한 공개 라벨 확장 연구
This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma who have previously completed the parent studies. After completion of the parent study, eligible participants will be offered the opportunity to participate in the long-term extension (LTE) study with lunsekimig.
The study duration will be up to 148 weeks with a treatment duration being up to 144 weeks.
연구 개요
연구 유형
등록 (추정된)
단계
- 2 단계
연락처 및 위치
연구 장소
-
-
-
Benoni, 남아프리카, 1500
- Investigational Site Number : 7100004
-
Benoni, 남아프리카, 1500
- Investigational Site Number : 7100005
-
Cape Town, 남아프리카, 7530
- Investigational Site Number : 7100003
-
Cape Town, 남아프리카, 7700
- Investigational Site Number : 7100002
-
Durban, 남아프리카, 4001
- Investigational Site Number : 7100001
-
Pretoria, 남아프리카, 0157
- Investigational Site Number : 7100006
-
-
-
-
-
Taipei, 대만, 110
- Investigational Site Number : 1580003
-
-
-
-
Seoul-teukbyeolsi
-
Seoul, Seoul-teukbyeolsi, 대한민국, 03722
- Investigational Site Number : 4100001
-
Seoul, Seoul-teukbyeolsi, 대한민국, 03080
- Investigational Site Number : 4100002
-
Seoul, Seoul-teukbyeolsi, 대한민국, 05030
- Investigational Site Number : 4100004
-
Seoul, Seoul-teukbyeolsi, 대한민국, 05505
- Investigational Site Number : 4100006
-
Seoul, Seoul-teukbyeolsi, 대한민국, 06351
- Investigational Site Number : 4100005
-
-
-
-
-
Leipzig, 독일, 04347
- Investigational Site Number : 2760001
-
Mainz, 독일, 55128
- Investigational Site Number : 2760005
-
-
-
-
-
Chihuahua City, 멕시코, 31000
- Investigational Site Number : 4840002
-
Durango, 멕시코, 34000
- Investigational Site Number : 4840003
-
Veracruz, 멕시코, 91900
- Investigational Site Number : 4840008
-
-
Nuevo León
-
Monterrey, Nuevo León, 멕시코, 66465
- Investigational Site Number : 4840004
-
-
Querétaro
-
San Juan del Río, Querétaro, 멕시코, 76800
- Investigational Site Number : 4840005
-
-
Yucatán
-
Mérida, Yucatán, 멕시코, 97070
- Investigational Site Number : 4840007
-
-
-
-
Arizona
-
Chandler, Arizona, 미국, 85224
- Chandler Clinical Research Trials- Site Number : 8400075
-
Tucson, Arizona, 미국, 85712
- Tucson Clinical Research Institute- Site Number : 8400085
-
-
Colorado
-
Aurora, Colorado, 미국, 80014
- Allianz Research Institute - Aurora- Site Number : 8400026
-
Wheat Ridge, Colorado, 미국, 80033
- Western States Clinical Research- Site Number : 8400014
-
-
Florida
-
Boynton Beach, Florida, 미국, 33435
- Helix Biomedics- Site Number : 8400114
-
Cutler Bay, Florida, 미국, 33157
- Beautiful Minds Clinical Research Center- Site Number : 8400049
-
Hialeah, Florida, 미국, 33010
- Qway Research - Hialeah- Site Number : 8400015
-
Miami, Florida, 미국, 33184
- High Quality Research- Site Number : 8400039
-
Miami, Florida, 미국, 33186
- Innovations Biotech- Site Number : 8400040
-
Miami, Florida, 미국, 33186
- New Access Medical Center- Site Number : 8400043
-
Miami, Florida, 미국, 33135
- Clintex Research Group - Miami - Southwest 27th Avenue- Site Number : 8400048
-
Miami Lakes, Florida, 미국, 33014
- Deluxe Health Center- Site Number : 8400045
-
Pembroke Pines, Florida, 미국, 33025
- Tellabio International Research Services- Site Number : 8400083
-
Pembroke Pines, Florida, 미국, 33029
- Alfa Medical Research LLC- Site Number : 8400146
-
Pensacola, Florida, 미국, 32503
- Avanza Medical Research Center- Site Number : 8400135
-
Saint Cloud, Florida, 미국, 34769
- Ilumina Medical Research- Site Number : 8400095
-
Sarasota, Florida, 미국, 34239
- Windom Allergy, Asthma and Sinus Specialists- Site Number : 8400019
-
-
Georgia
-
Cordele, Georgia, 미국, 31015
- Private Practice - Dr. David Kavtaradze- Site Number : 8400081
-
-
Massachusetts
-
Boston, Massachusetts, 미국, 02115
- Brigham & Women's Hospital- Site Number : 8400034
-
-
Michigan
-
Ann Arbor, Michigan, 미국, 48109
- University of Michigan Health System - Ann Arbor- Site Number : 8400004
-
-
Missouri
-
St Louis, Missouri, 미국, 63141
- Midwest Clinical Research Center - St. Louis- Site Number : 8400006
-
-
North Carolina
-
Charlotte, North Carolina, 미국, 28287
- Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400029
-
-
Ohio
-
Toledo, Ohio, 미국, 43617
- Asthma & Allergy Center - Toledo- Site Number : 8400017
-
-
Oklahoma
-
Edmond, Oklahoma, 미국, 73034
- OK Clinical Research- Site Number : 8400021
-
-
Pennsylvania
-
DuBois, Pennsylvania, 미국, 15801
- Clinical Research Associates of Central Pennsylvania- Site Number : 8400116
-
Pittsburgh, Pennsylvania, 미국, 15241
- Allergy & Clinical Immunology Associates Pittsburgh- Site Number : 8400007
-
-
Texas
-
Austin, Texas, 미국, 78759
- Orion Clinical Research- Site Number : 8400001
-
Boerne, Texas, 미국, 78006
- South Texas Medical Research Institute - TTS Research- Site Number : 8400010
-
Dallas, Texas, 미국, 75246
- Baylor University Medical Center- Site Number : 8400002
-
El Paso, Texas, 미국, 79903
- Western Sky Medical Research- Site Number : 8400023
-
McKinney, Texas, 미국, 75069
- Metroplex Pulmonary and Sleep Center- Site Number : 8400022
-
-
-
-
-
Rio de Janeiro, 브라질, 22241-180
- CCBR / IBPClin - Instituto Brasil de Pesquisa Clínica- Site Number : 0760006
-
São Paulo, 브라질, 05403-000
- Incor - Instituto do Coracao- Site Number : 0760011
-
-
Estado de Bahia
-
Salvador, Estado de Bahia, 브라질, 40060-330
- Associacao Proar- Site Number : 0760003
-
-
Goiás
-
Goiânia, Goiás, 브라질, 74605-020
- Universidade Federal de Goias- Site Number : 0760007
-
-
Paraná
-
Curitiba, Paraná, 브라질, 80030-110
- CETI - Centro de Estudos em Terapias Inovadoras- Site Number : 0760002
-
-
Pernambuco
-
Recife, Pernambuco, 브라질, 50070-550
- Instituto de Medicina Integral Professor Fernando Figueira- Site Number : 0760009
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, 브라질, 90610-000
- Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760001
-
-
Santa Catarina
-
Blumenau, Santa Catarina, 브라질, 89030-101
- Hospital Dia do Pulmão- Site Number : 0760005
-
-
-
-
-
Madrid, 스페인, 28007
- Investigational Site Number : 7240008
-
Madrid, 스페인, 28010
- Investigational Site Number : 7240011
-
-
Catalunya [Cataluña]
-
Barcelona, Catalunya [Cataluña], 스페인, 08017
- Investigational Site Number : 7240009
-
-
-
-
-
Buenos Aires, 아르헨티나, 1121
- Investigational Site Number : 0320005
-
Buenos Aires, 아르헨티나, 1414
- Investigational Site Number : 0320004
-
Buenos Aires, 아르헨티나, 1425
- Investigational Site Number : 0320001
-
Buenos Aires, 아르헨티나, 1122
- Investigational Site Number : 0320012
-
Buenos Aires, 아르헨티나, 1425
- Investigational Site Number : 0320011
-
La Plata, Buenos Aires, 아르헨티나, B1904CUL
- Investigational Site Number : 0320003
-
Mendoza, 아르헨티나, 5500
- Investigational Site Number : 0320009
-
Mendoza, 아르헨티나, 5500
- Investigational Site Number : 0320015
-
Santa Fe, 아르헨티나, 3000
- Investigational Site Number : 0320010
-
-
Buenos Aires
-
Berazategui, Buenos Aires, 아르헨티나, 1886
- Investigational Site Number : 0320007
-
Lobos, Buenos Aires, 아르헨티나, 7240
- Investigational Site Number : 0320013
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, 아르헨티나, 2000
- Investigational Site Number : 0320002
-
Rosario, Santa Fe Province, 아르헨티나, 2000
- Investigational Site Number : 0320006
-
Rosario, Santa Fe Province, 아르헨티나, 2000
- Investigational Site Number : 0320020
-
-
Tucumán Province
-
San Miguel de Tucumán, Tucumán Province, 아르헨티나, 4000
- Investigational Site Number : 0320008
-
-
-
-
-
Bradford, 영국, BD9 6DA
- Investigational Site Number : 8260008
-
Chertsey, 영국
- Investigational Site Number : 8260005
-
London, 영국, W1G 8HU
- Investigational Site Number : 8260011
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, 영국, CB2 2QQ
- Investigational Site Number : 8260001
-
-
Glasgow City
-
Glasgow, Glasgow City, 영국, G12 0YN
- Investigational Site Number : 8260004
-
-
-
-
-
Ashkelon, 이스라엘, 7830604
- Investigational Site Number : 3760006
-
Haifa, 이스라엘, 3104802
- Investigational Site Number : 3760001
-
Haifa, 이스라엘, 3436212
- Investigational Site Number : 3760008
-
Jerusalem, 이스라엘, 9103102
- Investigational Site Number : 3760003
-
Jerusalem, 이스라엘, 9112001
- Investigational Site Number : 3760002
-
Petah Tikva, 이스라엘, 4941492
- Investigational Site Number : 3760010
-
Rehovot, 이스라엘, 7610001
- Investigational Site Number : 3760004
-
Tel Aviv, 이스라엘, 6423906
- Investigational Site Number : 3760007
-
-
-
-
Roma
-
Rome, Roma, 이탈리아, 00168
- Investigational Site Number : 3800010
-
-
-
-
-
Calicut, 인도, 673008
- Investigational Site Number : 3560007
-
Hyderabad, 인도, 500084
- Investigational Site Number : 3560009
-
Kanpur, 인도, 208001
- Investigational Site Number : 3560008
-
Nagpur, 인도, 441203
- Investigational Site Number : 3560001
-
Pune, 인도, 411057
- Investigational Site Number : 3560004
-
-
-
-
-
Fukushima, 일본, 960-1295
- Investigational Site Number : 3920008
-
Kyoto, 일본, 610-0113
- Investigational Site Number : 3920006
-
Kyoto, 일본, 612-8555
- Investigational Site Number : 3920009
-
Miyazaki, 일본, 889-1692
- Investigational Site Number : 3920012
-
-
Kagawa-ken
-
Sakaidechō, Kagawa-ken, 일본, 762-8550
- Investigational Site Number : 3920002
-
-
Tokyo
-
Chūō, Tokyo, 일본, 104-0031
- Investigational Site Number : 3920011
-
-
Yamaguchi
-
Ube, Yamaguchi, 일본, 755-8505
- Investigational Site Number : 3920005
-
-
-
-
-
Beijing, 중국, 100144
- Investigational Site Number : 1560011
-
Changchun, 중국, 130021
- Investigational Site Number : 1560010
-
Changsha, 중국, 410015
- Investigational Site Number : 1560017
-
Chengde, 중국, 067020
- Investigational Site Number : 1560021
-
Guangzhou, 중국, 510150
- Investigational Site Number : 1560009
-
Guangzhou, 중국, 510000
- Investigational Site Number : 1560053
-
Guangzhou, 중국, 510163
- Investigational Site Number : 1560001
-
Guiyang, 중국, 550002
- Investigational Site Number : 1560037
-
Hefei, 중국, 230032
- Investigational Site Number : 1560006
-
Hohhot, 중국, 010050
- Investigational Site Number : 1560014
-
Lanzhou, 중국, 730000
- Investigational Site Number : 1560030
-
Nanchang, 중국, 330006
- Investigational Site Number : 1560007
-
Pingxiang, 중국, 337055
- Investigational Site Number : 1560002
-
Shanghai, 중국, 200433
- Investigational Site Number : 1560013
-
Shenyang, 중국, 110004
- Investigational Site Number : 1560015
-
Taiyuan, 중국, 030001
- Investigational Site Number : 1560057
-
Tianjin, 중국, 300211
- Investigational Site Number : 1560055
-
Wenzhou, 중국, 325027
- Investigational Site Number : 1560005
-
Wuhan, 중국, 430030
- Investigational Site Number : 1560003
-
Wuhan, 중국, 430030
- Investigational Site Number : 1560022
-
Xuzhou, 중국, 221006
- Investigational Site Number : 1560004
-
Yangzhou, 중국, 225000
- Investigational Site Number : 1560016
-
Zhanjiang, 중국, 524004
- Investigational Site Number : 1560012
-
-
-
-
Biobio
-
Concepción, Biobio, 칠레, 4070094
- Investigational Site Number : 1520013
-
-
Maule Region
-
Talca, Maule Region, 칠레, 3465584
- Investigational Site Number : 1520001
-
-
Reg Metropolitana de Santiago
-
Recoleta, Reg Metropolitana de Santiago, 칠레, 8420000
- Investigational Site Number : 1520015
-
Santiago, Reg Metropolitana de Santiago, 칠레, 7500587
- Investigational Site Number : 1520006
-
Santiago, Reg Metropolitana de Santiago, 칠레, 7500692
- Investigational Site Number : 1520005
-
Santiago, Reg Metropolitana de Santiago, 칠레, 7500698
- Investigational Site Number : 1520004
-
Santiago, Reg Metropolitana de Santiago, 칠레, 7750495
- Investigational Site Number : 1520002
-
-
Valparaiso
-
Quillota, Valparaiso, 칠레, 2260877
- Investigational Site Number : 1520008
-
Viña del Mar, Valparaiso, 칠레, 2531172
- Investigational Site Number : 1520011
-
Viña del Mar, Valparaiso, 칠레, 2540364
- Investigational Site Number : 1520012
-
-
-
-
Ontario
-
Ajax, Ontario, 캐나다, L1S 2J5
- Investigational Site Number : 1240013
-
Hamilton, Ontario, 캐나다, L8N 4A6
- Investigational Site Number : 1240003
-
-
Quebec
-
Sherbrooke, Quebec, 캐나다, J1H 5N4
- Investigational Site Number : 1240004
-
Trois-Rivières, Quebec, 캐나다, G8T 7A1
- Investigational Site Number : 1240001
-
-
-
-
-
Bursa, 터키 (Türkiye), 16059
- Investigational Site Number : 7920006
-
Istanbul, 터키 (Türkiye), 34098
- Investigational Site Number : 7920002
-
Istanbul, 터키 (Türkiye), 34854
- Investigational Site Number : 7920003
-
Kayseri, 터키 (Türkiye), 38039
- Investigational Site Number : 7920007
-
Kirikkale, 터키 (Türkiye), 71100
- Investigational Site Number : 7920008
-
Mersin, 터키 (Türkiye), 33070
- Investigational Site Number : 7920001
-
İzmit, 터키 (Türkiye), 41001
- Investigational Site Number : 7920005
-
-
-
-
-
Chęciny, 폴란드, 26-060
- Investigational Site Number : 6160004
-
-
Greater Poland Voivodeship
-
Poznan, Greater Poland Voivodeship, 폴란드, 60-693
- Investigational Site Number : 6160001
-
-
-
-
-
Mosonmagyaróvár, 헝가리, 9200
- Investigational Site Number : 3480004
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
Participants who completed the treatment period of Study DRI16762 or ACT18301, including the EOT visit, as per protocol
-
Participants with stable background therapy with moderate or high-dose ICS in combination with the following controller medications, as maintained during the respective parent study in which they have participated:
- For Study DRI16762: At least 1 and no more than 2 additional controllers (eg, LABA, LAMA, LTRA, or methylxanthines), with or without oral prednisone
- For Study ACT18301: LABA with or without LTRA
-
Participants who are able and willing to participate in the open-label extension study, and to comply with requested study visits and procedures
-
Contraception for male and female participants during the study intervention period and during 8 weeks following the last administration of study intervention. And:
For female participants:
- incapable of becoming pregnant, or
- not pregnant or breast feeding
- no eggs donation or cryopreserving eggs
For male participants:
-- No sperm donation or cryopreserving sperm
- Capable of giving signed informed consent
Exclusion Criteria:
Participants are excluded from the study if any of the following criteria apply:
- Participant who developed a new medical condition or a change in status of an established medical condition or requires a new treatment or medication prior to enrollment that, per Investigator's medical judgement would adversely affect participation of the participant in this study or would require permanent lunsekimig discontinuation, or participants potentially at risk of noncompliance to study procedures
- Participant who was diagnosed with a new pulmonary disease which may impair lung function
- Current smoker or active vaping of any products and/or marijuana smoking
- Prescription drug or substance abuse, including alcohol, considered significant by the Investigator
- History of hypersensitivity or allergy to lunsekimig or to any of the excipients used in the presentation or in preparation for administration of lunsekimig, or other allergy that, in the opinion of the Investigator, contraindicates participation in the study
- Participants who are receiving prohibited concomitant medications
- Participants who, during their participation in the parent study, developed an AE or an SAE deemed related to lunsekimig, which in the opinion of the Investigator could indicate that continued treatment with lunsekimig may present an unreasonable risk for the participant
The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Lunsekimig
Participants will receive subcutaneous injection of lunsekimig according to established dosing interval |
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Exposure-adjusted incidence rate of treatment-emergent adverse event (TEAE), including adverse events of special interest (AESI), and serious adverse event (SAE)
기간: From study baseline to week 148
|
Exposure-adjusted incidence rate is defined as the number of patients with at least one specific treatment emergent adverse event in question per 100 patients taking the treatment for 1 year. |
From study baseline to week 148
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Annualized rate of asthma exacerbation events
기간: From study baseline to weeks 48, 96 and 144
|
From study baseline to weeks 48, 96 and 144
|
|
|
Change from parent study baseline in pre-bronchodilator (BD) forced expiratory volume in 1 second (FEV1)
기간: From parent study baseline to weeks 48, 96 and 144
|
From parent study baseline to weeks 48, 96 and 144
|
|
|
Serum lunsekimig concentrations
기간: From study baseline to week 144
|
From study baseline to week 144
|
|
|
Incidence and titer of anti-drug antibodies (ADA) against lunsekimig
기간: From study baseline to week 144
|
From study baseline to week 144
|
|
|
Change from parent study baseline in Asthma Control Questionnaire5 (ACQ-5) score
기간: From parent study baseline to weeks 48, 96 and 144
|
The ACQ-5 is a questionnaire that measures the adequacy of asthma control and any changes in asthma control that may occur spontaneously or as a result of treatment. The ACQ-5 has five questions on the asthma symptoms and patients are asked to recall how their asthma has been during the previous week and to respond on a 7-point scale for each question (0 = no impairment, 6 = maximum impairment). The ACQ-5 score is the mean of the 5 questions and, therefore, between 0 (totally controlled) and 6 (severely uncontrolled). A high score indicates low asthma control. |
From parent study baseline to weeks 48, 96 and 144
|
|
Proportion of participants with ≥0.5-point reduction in each ACQ-5 score as compared to parent study baseline score
기간: From parent study baseline to weeks 48, 96 and 144
|
Defined as ACQ-5 responder analysis |
From parent study baseline to weeks 48, 96 and 144
|
|
Change from parent study baseline in Asthma Quality of Life Questionnaire Standardized Activites for 12 years and older (AQLQ[S] +12) domain and total scores
기간: From parent study baseline to weeks 48, 96 and 144
|
The AQLQ(S) + 12 was designed as a self-administered patient reported outcome to measure the functional impairments that are most troublesome to adolescents and adults ≥12 years of age as a result of their asthma. The instrument is comprised of 32 items, each rated on a 7-point Likert scales from 1 to 7. Higher scores indicate better quality of life. |
From parent study baseline to weeks 48, 96 and 144
|
공동 작업자 및 조사자
스폰서
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- LTS17231
- 2025-522896-27 (레지스트리 식별자: CTIS)
- U1111-1303-3645 (레지스트리 식별자: ICTRP)
- 2025 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://vivli.org
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .